Ccr2 deficiency impairs microglial accumulation and accelerates progression of Alzheimer-like disease
The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
Abstract
Microglia are the principal immune cells of the brain. In Alzheimer disease, these brain mononuclear phagocytes are recruited from the blood and accumulate in senile plaques. However, the role of microglia in Alzheimer disease has not been resolved. Microglia may be neuroprotective by phagocytosing amyloid-beta (Abeta), but their activation and the secretion of neurotoxins may also cause neurodegeneration. Ccr2 is a chemokine receptor expressed on microglia, which mediates the accumulation of mononuclear phagocytes at sites of inflammation. Here we show that Ccr2 deficiency accelerates early disease progression and markedly impairs microglial accumulation in a transgenic mouse model of Alzheimer disease (Tg2576). Alzheimer disease mice deficient in Ccr2 accumulated Abeta earlier and died prematurely, in a manner that correlated with Ccr2 gene dosage, indicating that absence of early microglial accumulation leads to decreased Abeta clearance and increased mortality. Thus, Ccr2-dependent microglial accumulation plays a protective role in the early stages of Alzheimer disease by promoting Abeta clearance.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The protective function of Ly6Clo monocytes in AD may also explain why CCR2 deficiency exacerbates disease severity [89, 238]”
From Microglia and monocytes in inflammatory CNS disease: integrating phenotype and function (2022) · cites this paper as [89]
In the citing paper
“CCR2 deficiency worsened AD pathology [89, 238]”
From Microglia and monocytes in inflammatory CNS disease: integrating phenotype and function (2022) · cites this paper as [89]
In the citing paper
“studies utilizing whole body irradiation chimeras, an experimental technique that is now recognized to condition the brain for monocyte infiltration [2, 3, 230], as well as transplant of BM-derived cells, reported that Ly6Chi monocytes infiltrate the AD mouse brain and accumulate around Aβ plaques.”
From Microglia and monocytes in inflammatory CNS disease: integrating phenotype and function (2022) · cites this paper as [89]
In the citing paper
“These infiltrating cells were thought to ameliorate disease evolution by phagocytosis and clearance of Aβ from the brain parenchyma [287] or by promotion of CCR2-mediated microglial accumulation in amyloid plaques and degradation of Aβ [89].”
From Microglia and monocytes in inflammatory CNS disease: integrating phenotype and function (2022) · cites this paper as [89]
In the citing paper
“Marrow-derived cells may have an ameliorative effect on neurodegenerative phenotypes in mice33,34, possibly due to their superior phagocytic capacity35.”
From Clonal hematopoiesis is associated with protection from Alzheimer’s disease (2023) · cites this paper as [34]
13 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Walsh, D. M., Klyubin, I., Fadeeva, J. V., Cullen, W. K., Anwyl, R., Wolfe, M. S., Rowan, M. J., & Selkoe, D. J. (2002) · Nature · doi:10.1038/416535a · Cited by 4,291
Correlative Memory Deficits, Aβ Elevation, and Amyloid Plaques in Transgenic Mice
Hsiao, K., Chapman, P., Nilsen, S., Eckman, C., Harigaya, Y., Younkin, S., Yang, F., & Cole, G. (1996) · Science · doi:10.1126/science.274.5284.99 · Cited by 4,210
Chemokines — Chemotactic Cytokines That Mediate Inflammation
Luster, A. D. (1998) · New England Journal of Medicine · doi:10.1056/nejm199802123380706 · Cited by 3,630
Self-citationThe many roles of chemokines and chemokine receptors in inflammation
Charo, I. F., & Ransohoff, R. M. (2006) · New England Journal of Medicine · doi:10.1056/nejmra052723 · Cited by 2,523 · cited 1×
“Chemokines are chemotactic cytokines that bind specific G protein–coupled receptors on the surface of cells and mediate the accumulation of leukocytes at sites of inflammatio”
BackgroundBard, F., Cannon, C., Barbour, R., Burke, R.-L., Games, D., Grajeda, H., Guido, T., Hu, K., Huang, J., Johnson-Wood, K., et al. (2000) · Nature Medicine · doi:10.1038/78682 · Cited by 2,012
RAGE and amyloid-β peptide neurotoxicity in Alzheimer's disease
Yan, S. D., Chen, X., Fu, J., Chen, M., Zhu, H., Roher, A., Slattery, T., Zhao, L., Nagashima, M., Morser, J., et al. (1996) · Nature · doi:10.1038/382685a0 · Cited by 2,012
Simard, A. R., Soulet, D., Gowing, G., Julien, J.-P., & Rivest, S. (2006) · Neuron · doi:10.1016/j.neuron.2006.01.022 · Cited by 1,265
Boring, L., Gosling, J., Chensue, S. W., Kunkel, S. L., Farese, R. V., Broxmeyer, H. E., & Charo, I. F. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119798 · Cited by 1,096
Metabolic Regulation of Brain Aβ by Neprilysin
Iwata, N., Tsubuki, S., Takaki, Y., Shirotani, K., Lu, B., Gerard, N. P., Gerard, C., Hama, E., Lee, H.-J., & Saido, T. C. (2001) · Science · doi:10.1126/science.1059946 · Cited by 961
Adult mouse astrocytes degrade amyloid-β in vitro and in situ
Wyss-Coray, T., Loike, J. D., Brionne, T. C., Lu, E., Anankov, R., Yan, F., Silverstein, S. C., & Husemann, J. (2003) · Nature Medicine · doi:10.1038/nm838 · Cited by 909
Cited by
Items 501–600 of 940
Dementia-associated changes of immune cell composition within the cerebrospinal fluid
Busse, S., Hoffmann, J., Michler, E., Hartig, R., Frodl, T., & Busse, M. (2021) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2021.100218 · Cited by 42
The Vascular-Immune Hypothesis of Alzheimer’s Disease
Mehta, R. I., & Mehta, R. I. (2023) · Biomedicines · doi:10.3390/biomedicines11020408 · Cited by 37
Neuroinflammatory Cytokines - The Common Thread in Alzheimer Pathogenesis
Griffin, W. S. T., Barger, S. W., Chairman, D. P. A. V., Professor of Geriatrics, N. A. D. S. A. I. M., & Professor of Geriatrics, N. A. D. S. A. I. M. (2011) · European Neurological Review · doi:10.17925/enr.2011.06.02.89 · Cited by 39
Staging anti-inflammatory therapy in Alzheimer’s disease
Lichtenstein, M. P. (2010) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2010.00142 · Cited by 39
Immunotherapeutic approaches for Alzheimer’s disease in transgenic mouse models
Wısnıewskı, T., & Boutajangout, A. (2009) · Brain Structure and Function · doi:10.1007/s00429-009-0236-2 · Cited by 40
Stromal cell-derived factor 1α decreases β-amyloid deposition in Alzheimer's disease mouse model
Wang, Q., Xu, Y., Chen, J., Qin, Y., Liu, M., Liu, Y., Xie, M.-J., Yu, Z., Zhu, Z., & Wang, W. (2012) · Brain Research · doi:10.1016/j.brainres.2012.04.011 · Cited by 42
Connecting Malfunctioning Glial Cells and Brain Degenerative Disorders
Kaminsky, N., Bihari, O., Kanner, S., & Barzilai, A. (2016) · Genomics, Proteomics & Bioinformatics · doi:10.1016/j.gpb.2016.04.003 · Cited by 38
Thellung, S., Villa, V., Corsaro, A., Pellistri, F., Venezia, V., Russo, C., Aceto, A., Robello, M., & Florio, T. (2007) · Glia · doi:10.1002/glia.20559 · Cited by 38
Immunotherapy of cerebrovascular amyloidosis in a transgenic mouse model
Lifshitz, V., Weiss, R., Benromano, T., Kfir, E., Blumenfeld‐Katzir, T., Tempel-Brami, C., Assaf, Y., Xia, W., Wyss‐Coray, T., Weiner, H. L., et al. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2011.01.006 · Cited by 39
Review: Microglia in protein aggregation disorders: friend or foe?
Gentleman, S. (2013) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12017 · Cited by 38
Potential Immunotargets for Alzheimer's Disease Treatment Strategies
Fernández, P. L., Britton, G. B., & Rao, K. S. (2012) · Journal of Alzheimer's Disease · doi:10.3233/jad-2012-121222 · Cited by 37
The Bradykinin B1 Receptor Regulates Aβ Deposition and Neuroinflammation in Tg-SwDI Mice
Passos, G. F., Medeiros, R., Cheng, D., Vasilevko, V., LaFerla, F. M., & Cribbs, D. H. (2013) · The American Journal of Pathology · doi:10.1016/j.ajpath.2013.01.021 · Cited by 37
Absence of CD14 delays progression of prion diseases accompanied by increased microglial activation
Sakai, K., Hasebe, R., Takahashi, Y., Song, C.-H., Suzuki, A., Yamasaki, T., & Horiuchi, M. (2013) · Journal of Virology · doi:10.1128/jvi.02072-13 · Cited by 37
Peli1 impairs microglial Aβ phagocytosis through promoting C/EBPβ degradation
Xu, J., Yu, T., Pietronigro, E. C., Yuan, J., Arioli, J., Pei, Y., Luo, X., Ye, J., Constantin, G., Mao, C., et al. (2020) · PLoS Biology · doi:10.1371/journal.pbio.3000837 · Cited by 38
Host and Viral Factors Influencing the Pathogenesis of HIV-Associated Neurocognitive Disorders
Jayadev, S., & Garden, G. A. (2009) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-009-9154-6 · Cited by 42
SUMO1 impact on Alzheimer disease pathology in an amyloid-depositing mouse model
Knock, E., Matsuzaki, S., Takamura, H., Satoh, K., Rooke, G., Han, K., Zhang, H., Staniszewski, A., Katayama, T., Arancio, O., et al. (2017) · Neurobiology of Disease · doi:10.1016/j.nbd.2017.11.015 · Cited by 38
Althafar, Z. M. (2022) · Molecules · doi:10.3390/molecules27134124 · Cited by 35
Gupta, V. B., Hone, E., Pedrini, S., Doecke, J., O'Bryant, S., James, I., Bush, A. I., Rowe, C. C., Villemagne, V. L., Ames, D., et al. (2017) · Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring · doi:10.1016/j.dadm.2017.04.003 · Cited by 35
Wang, C., Wang, J., Zhu, Z., Hu, J., & Lin, Y. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1421076 · Cited by 46
Immune dysfunction in Alzheimer disease
Butovsky, O., Rosenzweig, N., Kleemann, K. L., Jorfi, M., Kuchroo, V. K., Tanzi, R. E., & Weiner, H. L. (2025) · Nature reviews. Neuroscience · doi:10.1038/s41583-025-00997-0 · Cited by 48
Neuroimmune Biomarkers in Mental Illness
Herron, J. W., Nerurkar, L., & Cavanagh, J. (2018) · Current topics in behavioral neurosciences · doi:10.1007/7854_2018_45 · Cited by 37
Monocytes in the Peripheral Clearance of Amyloid-β and Alzheimer’s Disease
Guo, H., Zhao, Z., Zhang, R., Chen, P., Zhang, X., Cheng, F., & Gou, X. (2019) · Journal of Alzheimer’s Disease · doi:10.3233/jad-181177 · Cited by 36
Sanati, M., Aminyavari, S., Khodagholi, F., Hajipour, M. J., Sadeghi, P., Noruzi, M., Moshtagh, A., Behmadi, H., & Sharifzadeh, M. S. (2021) · NeuroToxicology · doi:10.1016/j.neuro.2021.05.013 · Cited by 39
Yao, Y., & Tsirka, S. E. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.124891 · Cited by 37
Rivera-Escalera, F., Matousek, S. B., Ghosh, S., Olschowka, J. A., & O’Banion, M. K. (2014) · Neurobiology of Disease · doi:10.1016/j.nbd.2014.05.018 · Cited by 34
Becker, F., Kurmaeva, E., Gavins, F. N. E., Stevenson, E. V., Navratil, A. R., Jin, L., Tsunoda, I., Orr, A. W., Alexander, J. S., & Ostanin, D. V. (2016) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000731 · Cited by 34
Lecordier, S., Pons, V., Rivest, S., & ElAli, A. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2021.813536 · Cited by 37
Leucine‐rich repeat kinase 2 and Parkinson's disease
Kang, U., & Marto, J. A. (2016) · PROTEOMICS · doi:10.1002/pmic.201600092 · Cited by 40
Production of monocytic cells from bone marrow stem cells: therapeutic usage in Alzheimer’s disease
Magga, J. M., Savchenko, E., Malm, T., Rõlova, T., Pollari, E., Valonen, P. K., Lehtonen, Š., Jantunen, E., Aarnio, J., Lehenkari, P. P., et al. (2011) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2011.01390.x · Cited by 35
Costello, D. A., Keenan, K., McManus, R. M., Falvey, A., & Lynch, M. A. (2016) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2016.04.001 · Cited by 33
Guo, W., Wang, H., Zou, S., Dubner, R. A., & Ren, K. (2012) · Neuroscience Bulletin · doi:10.1007/s12264-012-1218-6 · Cited by 33
Luo, Q., Schnöder, L., Hao, W., Litzenburger, K., Decker, Y., Tomic, I., Menger, M. D., Fassbender, K. C., & Liu, Y. (2022) · Aging Cell · doi:10.1111/acel.13679 · Cited by 36
Sargeant, T. J., & Fourrier, C. (2022) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2022.09.015 · Cited by 32
Chemokines and Their Receptors in Intracerebral Hemorrhage
Yao, Y., & Tsirka, S. E. (2012) · Translational Stroke Research · doi:10.1007/s12975-012-0155-z · Cited by 32
Interleukin-1 Receptor 1 Deletion in Focal and Diffuse Experimental Traumatic Brain Injury in Mice
Chung, J. Y., Krapp, N., Wu, L., Lüle, S., McAllister, L. M., Edmiston, W. J., Martin, S. P., Levy, E. S., Songtachalert, T., Sherwood, J. S., et al. (2018) · Journal of Neurotrauma · doi:10.1089/neu.2018.5659 · Cited by 32
Self-citationBridging the Gap between Alzheimer’s Disease and Alzheimer’s-like Diseases in Animals
Gołaszewska, A., Bik, W., Motyl, T., & Orzechowski, A. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20071664 · Cited by 34
Aurelian, L., & Balan, I. S. (2019) · Psychopharmacology · doi:10.1007/s00213-019-05220-4 · Cited by 37
Schwartz, M., Ramos, J. M. P., & Ben-Yehuda, H. (2020) · The Journal of Immunology · doi:10.4049/jimmunol.1900844 · Cited by 34
Huang, X., Wang, Y., & Xiang, Y. (2022) · EBioMedicine · doi:10.1016/j.ebiom.2022.104263 · Cited by 32
Yang, Y., García-Cruzado, M., Zeng, H., Camprubí-Ferrer, L., Bahatyrevich-Kharitonik, B., Bachiller, S., & Deierborg, T. (2023) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2023.07.006 · Cited by 31
Alzheimer’s disease: The role of T lymphocytes in neuroinflammation and neurodegeneration
Asamu, M. O., Oladipo, O. O., Abayomi, O. A., & Adebayo, A. A. (2023) · Brain Research · doi:10.1016/j.brainres.2023.148589 · Cited by 37
CCR2/CCL2-mediated inflammation protects photoreceptor cells from amyloid-β-induced apoptosis
Bruban, J., Maoui, A., Chalour, N., An, N., Jonet, L., Feumi, C., Tréton, J., Sennlaub, F., Béhar‐Cohen, F., Mascarelli, F., et al. (2011) · Neurobiology of Disease · doi:10.1016/j.nbd.2011.01.004 · Cited by 33
Leukocyte CCR2 Expression Is Associated with Mini-Mental State Examination Score in Older Adults
Harries, L. W., Bradley-Smith, R. M., Llewellyn, D. J., Pilling, L. C., Fellows, A. D., Henley, W., Hernandez, D. G., Guralnik, J. M., Bandinelli, S., Singleton, A., et al. (2012) · Rejuvenation Research · doi:10.1089/rej.2011.1302 · Cited by 34
Brown, A. M. (2015) · Clinical and Translational Medicine · doi:10.1186/s40169-015-0049-2 · Cited by 32
Role of CCR2 in immunobiology and neurobiology
Yamasaki, R., Liu, L., Lin, J., & Ransohoff, R. M. (2011) · Clinical and Experimental Neuroimmunology · doi:10.1111/j.1759-1961.2011.00024.x · Cited by 33
Manso, Y., Carrasco, J., Comes, G., Adlard, P. A., Bush, A. I., & Hidalgo, J. (2012) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-012-1045-y · Cited by 31
Cao, B., Zhang, X., Du, C.-Y., Liu, Z., Qiu, Y., & Peng, Y.-P. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.00187 · Cited by 30
Lasting Changes to Circulating Leukocytes in People with Mild SARS-CoV-2 Infections
Kennedy, A. E., Cook, L. E., Breznik, J. A., Cowbrough, B., Wallace, J. G., Huynh, A., Smith, J. W., Son, K., Stacey, H. D., Ang, J. C., et al. (2021) · Viruses · doi:10.3390/v13112239 · Cited by 36
The Role of Glutamate and the Immune System in Organophosphate-induced CNS Damage
Eisenkraft, A., Falk, A., & Finkelstein, A. (2013) · Neurotoxicity Research · doi:10.1007/s12640-013-9388-1 · Cited by 30
Pathological networking: a new approach to understanding COPD
Sabroe, I., Parker, L. C., CALVERLEY, P. M. A., Dower, S., & Whyte, M. K. B. (2007) · Postgraduate Medical Journal · doi:10.1136/thx.2007.077768 · Cited by 30
Kimura, A., Yoshikura, N., Hayashi, Y., & Inuzuka, T. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-170519 · Cited by 34
McKinsey, G. L., Santander, N. G., Zhang, X., Kleemann, K. L., Tran, L. T., Katewa, A., Conant, K., Barraza, M., Waddell, K., Lizama, C. O., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-57684-y · Cited by 33
Neuroimmune nexus of depression and dementia: Shared mechanisms and therapeutic targets
Herman, F. J., Simkovic, S. J., & Pasinetti, G. M. (2019) · British Journal of Pharmacology · doi:10.1111/bph.14569 · Cited by 29
Expression pattern of Ccr2 and Cx3cr1 in inherited retinal degeneration
Kohno, H., Koso, H., Okano, K., Sundermeier, T. R., Saitô, S., Watanabe, S., Tsuneoka, H., & Sakai, T. (2015) · Journal of Neuroinflammation · doi:10.1186/s12974-015-0408-3 · Cited by 33
Dysregulation of chemokine receptor expression and function in leukocytes from ALS patients
Perner, C., Perner, F., Stubendorff, B., Förster, M., Witte, O. W., Heidel, F. H., Prell, T., & Großkreutz, J. (2018) · Journal of Neuroinflammation · doi:10.1186/s12974-018-1135-3 · Cited by 31
Immunotherapy in Alzheimer's Disease: Where Do We Stand? Where Should We Go?
von Bernhardi, R. (2010) · Journal of Alzheimer's Disease · doi:10.3233/jad-2010-1248 · Cited by 28
Barrett, J. P., Minogue, A. M., Jones, R. S., Ribeiro, C. S., Kelly, R. J., & Lynch, M. A. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-142076 · Cited by 28
Inhibition of JAK2 attenuates the increase in inflammatory markers in microglia from APP/PS1 mice
Jones, R. S., Minogue, A. M., Fitzpatrick, O. M., & Lynch, M. A. (2015) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2015.04.018 · Cited by 31
Microglia express functional 11β‐hydroxysteroid dehydrogenase type 1
Gottfried‐Blackmore, A., Sierra, A., Mcewen, B. S., Ge, R., & Bulloch, K. (2010) · Glia · doi:10.1002/glia.21007 · Cited by 27
Myeloid cells in vascular dementia and Alzheimer's disease: Possible therapeutic targets?
García‐Culebras, A., Cuartero, M. I., Peña‐Martínez, C., Moraga, A., Vázquez‐Reyes, S., Castro-Millán, F. J., Cortés‐Canteli, M., Lizasoaín, I., & Moro, M. Á. (2023) · British Journal of Pharmacology · doi:10.1111/bph.16159 · Cited by 36
Tian, L., Long, G., Zhu, S., Wang, Y., Xu, P., Liu, L., Yao, H., Fang, S., Chen, S., & Li, S. (2025) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2427257122 · Cited by 27
Bruna, F., & Scodeller, P. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.675664 · Cited by 27
Pi, T., Lang, G.-P., Liu, B., & Shi, J. (2021) · Current Neuropharmacology · doi:10.2174/1570159x19666210809101945 · Cited by 29
Microglial activation in Alzheimer's disease: The role of flavonoids and microRNAs
Medrano-Jiménez, E., Meza‐Sosa, K. F., Aragon, J. A. U., Secundino, I., Pedraza-Alva, G., & Pérez-Martínez, L. (2022) · Journal of Leukocyte Biology · doi:10.1002/jlb.3mr1021-531r · Cited by 28
Biological agents and the aging brain: glial inflammation and neurotoxic signaling
Latham, A. S., Moreno, J. A., & Geer, C. E. (2023) · Frontiers in Aging · doi:10.3389/fragi.2023.1244149 · Cited by 29
Weiss, R., Lifshitz, V., & Frenkel, D. (2010) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2010.11.012 · Cited by 27
Lessons Learned about Neurodegeneration from Microglia and Monocyte Depletion Studies
Lund, H., Pieber, M., & Harris, R. A. (2017) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2017.00234 · Cited by 27
Martínez-Mármol, R., Mohannak, N., Qian, L., Wang, T., Gormal, R. S., Ruitenberg, M. J., Vanhaesebroeck, B., Coulson, E. J., & Meunier, F. A. (2019) · The Journal of Neuroscience · doi:10.1523/jneurosci.0674-19.2019 · Cited by 28
Cerebral and Peripheral Amyloid Phagocytes— an Old Liaison with a New Twist
Jucker, M., & Heppner, F. L. (2008) · Neuron · doi:10.1016/j.neuron.2008.06.014 · Cited by 26
Sabahi, M., Joshaghanian, A., Dolatshahi, M., Jabbari, P., Rahmani, F., & Rezaei, N. (2021) · Journal of Molecular Neuroscience · doi:10.1007/s12031-021-01818-6 · Cited by 26
Chen, S., He, C.-Y., Shen, Y., Zeng, G., Tian, D., Cheng, Y., Xu, M., Fan, D., Tan, C., Shi, A., et al. (2021) · Neuroscience Bulletin · doi:10.1007/s12264-021-00779-5 · Cited by 27
Lorenzini, L., Giuliani, A., Sivilia, S., Baldassarro, V. A., Fernández, M., Margotti, M. L., Giardino, L., Fontani, V., Rinaldi, S., & Calzà, L. (2016) · Scientific Reports · doi:10.1038/srep35719 · Cited by 26
SCHWARTZ, M., & Ziv, Y. (2008) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2008.03.006 · Cited by 30
Assessment of Retinal Function and Morphology in Aging Ccl2 Knockout Mice
Vessey, K. A., Waugh, M., Jobling, A. I., Phipps, J. A., Ho, T., Trogrlic, L., Greferath, U., & Fletcher, E. L. (2015) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.14-15334 · Cited by 27
Couturier, J., Page, G., Morel, M., Gontier, C., Lecron, J., Pontcharraud, R., Fauconneau, B., & Paccalin, M. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-100258 · Cited by 31
Potential importance of B cells in aging and aging-associated neurodegenerative diseases
Biragyn, A., Aliseychik, M., & Rogaev, E. (2017) · Seminars in Immunopathology · doi:10.1007/s00281-016-0615-8 · Cited by 25
Vérité, J., Janet, T., Chassaing, D., Fauconneau, B., Rabeony, H., & Page, G. (2018) · Journal of Neuroinflammation · doi:10.1186/s12974-018-1220-7 · Cited by 26
Translatomic analysis of regenerating and degenerating spinal motor neurons in injury and ALS
Shadrach, J. L., Stansberry, W. M., Milen, A. M., Ives, R. E., Fogarty, E. A., Antonellis, A., & Pierchala, B. A. (2021) · iScience · doi:10.1016/j.isci.2021.102700 · Cited by 28
Hohsfield, L. A., Tsourmas, K. I., Ghorbanian, Y., Syage, A. R., Kim, S. J., Cheng, Y., Furman, S., Inlay, M. A., Lane, T. E., & Green, K. N. (2022) · Glia · doi:10.1002/glia.24144 · Cited by 26
Harada, K., Hide, I., Seki, T., Tanaka, S., Nakata, Y., & Sakai, N. (2011) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07170.x · Cited by 25
Effects of 56Fe radiation on hippocampal function in mice deficient in chemokine receptor 2 (CCR2)
Raber, J., Allen, A. R., Rosi, S., Sharma, S., Dayger, C. A., Davis, M. J., & Fike, J. R. (2013) · Behavioural Brain Research · doi:10.1016/j.bbr.2013.03.003 · Cited by 25
Manso, Y., Comes, G., López, J. C., Belfiore, M., Molinero, A., Giralt, M., Carrasco, J., Adlard, P. A., Bush, A. I., Delgado-Garcia, J. M., et al. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-151025 · Cited by 30
Sackmann, V., Ansell, A., Sackmann, C., Lund, H., Harris, R. A., Hallbeck, M., & Nilsberth, C. (2017) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2017.08.022 · Cited by 28
Potential immunotherapy for Alzheimer disease and age-related dementia
Schwartz, M., Arad, M., & Ben-Yehuda, H. (2019) · Phlebolymphology · doi:10.31887/dcns.2019.21.1/mschwartz · Cited by 30
Boyd, H., & Booth‐Jones, M. (2012) · Brain Disorders & Therapy · doi:10.4172/bdt.1000101 · Cited by 25
Blockade of chloride intracellular ion channel 1 stimulates Aβ phagocytosis
Paradisi, S., Matteucci, A., Fabrizi, C., Denti, M. A., Abeti, R., Breit, S. N., Malchiodi‐Albedi, F., & Mazzanti, M. (2008) · Journal of Neuroscience Research · doi:10.1002/jnr.21693 · Cited by 28
Zhang, H., Lin, A., Gong, P., Chen, Y., Ye, R. D., Qian, F., Zhang, Y., & Yu, Y. (2020) · The Journal of Neuroscience · doi:10.1523/jneurosci.0455-20.2020 · Cited by 24
Pimentel‐Coelho, P. M., Michaud, J.-P., & Rivest, S. (2015) · Behavioural Brain Research · doi:10.1016/j.bbr.2015.02.053 · Cited by 24
The emerging role of the microbiome in Alzheimer's disease
Wasén, C., Simonsen, E., Ekwudo, M. N., Profant, M. R., & Cox, L. M. (2022) · International review of neurobiology · doi:10.1016/bs.irn.2022.09.001 · Cited by 25
Evidence of disturbed insulin signaling in animal models of Alzheimer’s disease
Alves, S. S., Servilha‐Menezes, G., Rossi, L., da Silva-Júnior, R. M. P., & Garcia‐Cairasco, N. (2023) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2023.105326 · Cited by 27
Zaritsky, L. A., Gama, L., & Clements, J. E. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1103024 · Cited by 25
Regenerative cross talk between cardiac cells and macrophages
Whitehead, A. J., & Engler, A. J. (2021) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00056.2021 · Cited by 27
Revuelta, M., Urrutia, J., Villarroel, Á., & Casis, Ó. (2022) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2022.868842 · Cited by 25
Cholesterol, CCR2, and monocyte phenotypes in atherosclerosis
Nahrendorf, M., & Świrski, F. K. (2017) · European Heart Journal · doi:10.1093/eurheartj/ehx098 · Cited by 24
Matatall, K. A., Wathan, T. K., Nguyen, M., Chen, H., McDonald, A., Qi, G., Belk, J. A., Florez, M. A., Le, D. T., Olarinde, T., et al. (2025) · Cell Stem Cell · doi:10.1016/j.stem.2025.06.006 · Cited by 23
The evolution of microglia replacement: A new paradigm for CNS disease therapy
Rao, Y., Bai, Y., Li, X., Du, B., & Peng, B. (2025) · Cell stem cell · doi:10.1016/j.stem.2025.10.014 · Cited by 27
Koca, S., Kiris, İ., Şahin, Ş., Çınar, N., Karşıdağ, S., Hanağası, H. A., Yıldız, G. B., & Baykal, A. T. (2022) · Neuroscience Letters · doi:10.1016/j.neulet.2022.136799 · Cited by 24
Netzahualcoyotzi, C., Santillán‐Cigales, J. J., Adalid-Peralta, L. V., & Velasco, I. (2024) · Journal of Neurochemistry · doi:10.1111/jnc.16106 · Cited by 26
Amyloid-β Activates Microglia and Regulates Protein Expression in a Manner Similar to Prions
Tu, J., Chen, B., Yang, L., Qi, K., Lu, J. N., & Zhao, D. (2015) · Journal of Molecular Neuroscience · doi:10.1007/s12031-015-0553-2 · Cited by 24
Shan, Z., Hirai, Y., Nakayama, M., Hayashi, R., Yamasaki, T., Hasebe, R., Song, C., & Horiuchi, M. (2017) · Journal of General Virology · doi:10.1099/jgv.0.000907 · Cited by 25
Metadata
- Authors
- El Khoury, J., Toft, M., Hickman, S. E., Means, T. K., Terada, K., Geula, C., & Luster, A. D.
- Affiliations
- Okayama University (JP)
- Northwestern University (US)
- Corresponding author
- Luster, Andrew D
- Venue
- Nature Medicine
- Published
- 2007-03-11
- Volume
- 13
- Issue
- 4
- Pages
- 432-438
- ISSN
- 1078-8956 (ISSN-L)
- 1546-170X
- OpenAlex
- W2097867538
- Cited by
- 915
- References
- 51
- Citations by year
- 2026: 29 · 2025: 27 · 2024: 41 · 2023: 35 · 2022: 44 · 2021: 70 · 2020: 51 · 2019: 37 · 2018: 42 · 2017: 51 · 2016: 51 · 2015: 60 · 2014: 43 · 2013: 53 · 2012: 70
- FWCI
- 34.66
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Medicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- American Health Assistance Foundation
- Dana Foundation
- Gladstone Institutes
- National Institutes of Health
- Topics
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neurological Disease Mechanisms and Treatments
- Keywords
- CCR2, chemokine receptors, microglia, Alzheimer's disease, amyloid-beta clearance, Tg2576 mice, disease progression, neuroinflammation, gene dosage, neuroprotection
- MeSH terms
- Alzheimer Disease, Analysis of Variance, Animals, Brain, Crosses, Genetic, Enzyme-Linked Immunosorbent Assay, Flow Cytometry, Immunohistochemistry, Monocytes, Amyloid beta-Peptides, Microglia, Mice, Knockout, Models, Immunological, Chemokines, Mice, Receptors, CCR2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.